✦ LIBER ✦

A phase II trial of zd0473 in patients with metastatic breast cancer. A National Cancer Institute of Canada clinical trials group study (NCIC CTG-IND 129)

✍ Scribed by T.A. Vandenberg; K.A. Gelmon; L. Panasci; M. Crump; B. Norris; A. Tomiak; T. Shenkier; L. Douglas; S. Matthews; L.K. Seymour

Book ID: 117658563
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 166 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81200-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of ZD0473 and docetaxel

A phase I study of ZD0473 and docetaxel given once every three weeks in patients with advanced refractory cancer. A National Cancer Institute of Canada-Clinical Trials Group Study (NCIC CTG-IND 131)

✍ K.A. Gelmon; D. Stewart; D. Ayers; D. Fry; L. Douglas; L.W. McIntosh; L.K. Seymo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Phase II study of flutamide in patients

Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study

✍ Daniele J. Perrault; Diane M. Logan; David J. Stewart; Vivien H. C. Bramwell; Al 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 271 KB

The National Cancer Institute of Canada (NCIC) Clinical Trials Group conducted a phase II study of the oral antiandrogen flutamide in 33 patients with metastatic breast cancer. Eight patients had received no prior systemic therapy for their metastatic disease and 13 had only one site of metastasis.

Phase II study of docetaxel (taxotere) i

Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer. A trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG)

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 133 KB

A phase I study of T900607 given once ev

A phase I study of T900607 given once every three weeks in patients with advanced refractory cancer. A National Cancer Institute of Canada-Clinical Trials Group Study (NCIC CTG-IND 130)

✍ K.A. Gelmon; K. Belanger; C. Britton; D. Soulières; S. Janke; J. Dionne; J. Powe 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A randomized crossover trial of tamoxife

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

✍ Carol A. Sawka; Kathleen I. Pritchard; Wendy Shelley; Gerrit DeBoer; Alexander H 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 32 KB

Characteristics of lung cancer patients

Characteristics of lung cancer patients entered on a Canadian palliative radiotherapy study (National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC.15 study)

✍ Dixon, P; Brundage, M; Palmer, M; Zee, B; Peter, J; Leong, C; Mulroy, L; Wright, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB